Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Access and safety of dexamethasone in multiple myeloma patients].
Slimano F, Tournamille JF, Bardin C, Madelaine I, Hulin C, Moreau P, Rioufol C. Slimano F, et al. Among authors: rioufol c. Bull Cancer. 2023 Jun;110(6):731-733. doi: 10.1016/j.bulcan.2023.05.001. Epub 2023 May 22. Bull Cancer. 2023. PMID: 37225617 French. No abstract available.
Monitoring multidimensional aspects of quality of life after cancer immunotherapy: protocol for the international multicentre, observational QUALITOP cohort study.
Vinke PC, Combalia M, de Bock GH, Leyrat C, Spanjaart AM, Dalle S, Gomes da Silva M, Fouda Essongue A, Rabier A, Pannard M, Jalali MS, Elgammal A, Papazoglou M, Hacid MS, Rioufol C, Kersten MJ, van Oijen MG, Suazo-Zepeda E, Malhotra A, Coquery E, Anota A, Preau M, Fauvernier M, Coz E, Puig S, Maucort-Boulch D. Vinke PC, et al. Among authors: rioufol c. BMJ Open. 2023 Apr 27;13(4):e069090. doi: 10.1136/bmjopen-2022-069090. BMJ Open. 2023. PMID: 37105689 Free PMC article.
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.
Sesques P, Ferrant E, Safar V, Wallet F, Tordo J, Dhomps A, Karlin L, Brisou G, Vercasson M, Hospital-Gustem C, Schwiertz V, Ranchon F, Rioufol C, Choquet M, Sujobert P, Ghergus D, Bouafia F, Golfier C, Lequeu H, Lazareth A, Novelli S, Devic P, Traverse Glehen A, Viel S, Venet F, Mialou V, Hequet O, Chauchet A, Arkam Y, Nicolas-Virelizier E, Peyrade F, Cavalieri D, Ader F, Ghesquières H, Salles G, Bachy E. Sesques P, et al. Among authors: rioufol c. Am J Hematol. 2020 Nov;95(11):1324-1333. doi: 10.1002/ajh.25951. Epub 2020 Aug 25. Am J Hematol. 2020. PMID: 32744738 Free article. Clinical Trial.
Effect of carbamazepine on fluindione's anticoagulant activity: a case report.
Bauler S, Janoly-Dumenil A, Sancho PO, Fromager F, Gouraud A, Rioufol C, Jacquin-Courtois S, Luaute J, Rode G. Bauler S, et al. Among authors: rioufol c. Therapie. 2012 Sep-Oct;67(5):488-9. doi: 10.2515/therapie/2012057. Epub 2012 Dec 18. Therapie. 2012. PMID: 23241262 No abstract available.
Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.
Bourmaud A, Henin E, Tinquaut F, Regnier V, Hamant C, Colomban O, You B, Ranchon F, Guitton J, Girard P, Freyer G, Tod M, Rioufol C, Trillet-Lenoir V, Chauvin F. Bourmaud A, et al. Among authors: rioufol c. BMC Res Notes. 2015 Jul 4;8:291. doi: 10.1186/s13104-015-1231-8. BMC Res Notes. 2015. PMID: 26142140 Free PMC article.
96 results